Hims & Hers Health Soars over 6% on FDA-Approved GLP-1 Treatment Expansion
Hims & Hers Health Inc. (HIMS) surged 10.13% in pre-market trading on Thursday, marking a significant upward movement for the telehealth company.The sharp increase appears to be driven by the...